Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes.

Trial Profile

Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Nov 2011

At a glance

  • Drugs Glimepiride (Primary) ; Pioglitazone (Primary) ; Voglibose (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Nov 2011 Last checked against ISRCTN: Current Controlled Trials record.
    • 26 Sep 2007 The expected completion date for this trial is now 31 Dec 2006.
    • 24 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top